시장보고서
상품코드
1955503

중재적 폐 솔루션 시장 보고서(2026년)

Interventional Lung Solutions Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

중재적 폐 솔루션 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 24억 7,000만 달러에서 2026년에는 26억 8,000만 달러로, CAGR 8.3%로 확대될 것으로 예상됩니다. 지난 수년간의 성장세는 COPD 및 폐암 유병률 증가, 외과적 폐중재술의 한계, 기관지경 기술의 발전, 병원에서의 최소침습수술 도입 확대, 의료비 지출 증가 등이 원인으로 추정됩니다.

중재적 폐 솔루션 시장 규모는 향후 몇 년간 견조한 성장이 전망됩니다. 2030년에는 36억 6,000만 달러에 달하고, CAGR은 8.1%가 될 전망입니다. 예측 기간 동안의 성장 요인으로는 호흡기질환을 앓고 있는 고령 인구의 증가, 로봇 보조 중재의 보급 확대, 외래 폐 시술의 확대, 조기 폐암 진단에 대한 관심 증가, 내비게이션 기관지경 기술의 발전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 최소침습적 폐 시술의 보급 확대, 로봇 기관지경 시스템의 활용 증가, 폐용적 감소장치에 대한 수요 확대, 영상유도 폐중재술의 확대, 일회용 기관지경 선호도 증가 등을 꼽을 수 있습니다.

호흡기질환의 유병률 증가는 향후 몇 년 동안 중재적 폐 솔루션 시장의 성장을 견인할 것으로 예상됩니다. 호흡기질환이란 폐와 기도에 영향을 미쳐 정상적인 호흡 기능을 손상시켜 호흡곤란을 유발하는 병태를 말합니다. 이러한 질병의 증가는 주로 대기오염의 심화로 인한 유해한 부유 미립자 물질과 자극 물질에 만성적으로 노출된 데서 기인합니다. 중재적 폐 솔루션은 만성 폐질환 환자의 폐 기능을 개선하고 증상을 완화하는 최소침습적 시술을 제공함으로써 호흡기질환의 관리를 돕습니다. 예를 들어, 영국에 본사를 둔 학술지 플랫폼 BioMed Central Ltd에 따르면, 2025년 5월 기준 만성폐쇄성폐질환(COPD)의 전 세계 유병률은 10.3%로 추정되며, 2050년까지 6억 명에 달할 것으로 예측됩니다. 현재 천식은 전 세계적으로 약 2억 6,200만 명이 앓고 있습니다. 이러한 호흡기질환의 유병률 증가는 중재적 폐 솔루션 시장의 성장을 견인하고 있습니다.

중재적 폐 솔루션 시장의 주요 기업들은 폐암 진단의 정확성 향상, 최소침습 수술 지원, 정밀한 탐색 및 생검 기능을 통한 환자 결과 개선을 위한 첨단 기술 개발에 주력하고 있습니다. 예를 들어, 'Ion Endoluminal System'은 최소침습 폐 수술용으로 설계된 로봇 보조 플랫폼으로, 기도의 정확한 탐색을 통해 작거나 접근하기 어려운 폐 결절에 접근할 수 있게 해줍니다. 예를 들어, 2024년 4월 미국 비영리 단체인 H. Lee Moffitt Cancer Center and Research Institute Foundation Inc.는 새로운 Ion Robotic Bronchoscopy 플랫폼을 도입했습니다. 이를 통해 첨단 광섬유 기술과 최소침습적 카테터 시스템을 활용한 중재적 폐질환 치료 프로그램을 추진하고 있습니다. 이 시스템은 광섬유 기술과 최소 직경의 카테터를 활용하여 폐의 모든 부위에 도달할 수 있습니다. 이 시스템은 180°의 관절 가동범위를 갖춘 초박형 고탄성 카테터, 통합형 실시간 영상, 형상 감지 기술을 특징으로 하며, 접근이 어려운 폐 주변부 결절에 대한 정밀한 탐색과 생검이 가능합니다. 조직 채취에 있어 탁월한 안정성과 정확성을 제공하여 의사가 18개 폐 부위 전체에 도달할 수 있도록함으로써 폐암을 조기에 발견할 수 있도록 돕습니다.

자주 묻는 질문

  • 중재적 폐 솔루션 시장 규모는 어떻게 변화하고 있나요?
  • 중재적 폐 솔루션 시장의 성장 요인은 무엇인가요?
  • 호흡기질환의 유병률 증가는 중재적 폐 솔루션 시장에 어떤 영향을 미치나요?
  • 중재적 폐 솔루션 시장의 주요 기업들은 어떤 기술 개발에 주력하고 있나요?
  • Ion Endoluminal System은 어떤 기능을 가지고 있나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM 26.03.24

Interventional lung solutions refer to minimally invasive procedures and technologies used to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions commonly include bronchoscopy interventions, endobronchial valves, and image-guided therapies that enhance lung function and improve patient outcomes.

The primary product types of interventional lung solutions include bronchoscopes, endobronchial ultrasound needles, pleuroscopes, airway stents, and other related devices. Bronchoscopes are medical instruments used to visualize and examine the airways and lungs, typically inserted through the nose or mouth to diagnose and treat respiratory conditions. Technologies linked with bronchoscopes include robotic surgery, laser therapy, and electromagnetic navigation bronchoscopy. The procedures performed include bronchoscopy, thoracoscopy, pleuroscopy, and others. These solutions are applied in lung cancer treatment, COPD management, and sleep apnea therapy and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

Tariffs have influenced the interventional lung solutions market by raising costs for imported medical devices, imaging components, and robotic surgical systems. These impacts are most pronounced in bronchoscopy equipment and robotic-assisted technologies, particularly across North America, Europe, and Asia-Pacific where device manufacturing is globally integrated. Increased tariffs have led to higher procurement costs for hospitals and specialty clinics. Positively, tariffs have driven local manufacturing initiatives and accelerated innovation in cost-efficient interventional lung devices.

The interventional lung solutions market research report is one of a series of new reports from The Business Research Company that provides interventional lung solutions market statistics, including interventional lung solutions industry global market size, regional shares, competitors with a interventional lung solutions market share, detailed interventional lung solutions market segments, market trends and opportunities, and any further data you may need to thrive in the interventional lung solutions industry. This interventional lung solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional lung solutions market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.68 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing prevalence of copd and lung cancer, limitations of surgical lung interventions, advancements in bronchoscopy technology, growing hospital adoption of minimally invasive procedures, rising healthcare expenditure.

The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growth in aging population with respiratory diseases, increasing adoption of robotic-assisted interventions, expansion of outpatient pulmonary procedures, rising focus on early lung cancer diagnosis, technological advancements in navigation bronchoscopy. Major trends in the forecast period include rising adoption of minimally invasive pulmonary procedures, increasing use of robotic bronchoscopy systems, growing demand for lung volume reduction devices, expansion of image-guided interventional lung therapies, increasing preference for disposable bronchoscopes.

The rising prevalence of respiratory diseases is expected to drive the growth of the interventional lung solutions market in the coming years. Respiratory diseases encompass medical conditions that affect the lungs and airways, impairing normal respiratory function and making breathing difficult. The increase in these diseases is largely attributed to higher levels of air pollution, which lead to chronic exposure to harmful airborne particles and irritants. Interventional lung solutions assist in managing respiratory diseases by offering minimally invasive procedures that enhance lung function and alleviate symptoms in patients with chronic pulmonary conditions. For example, in May 2025, according to BioMed Central Ltd, a UK-based journal platform, the global prevalence of chronic obstructive pulmonary disease (COPD) is estimated at 10.3%, with the number of affected individuals projected to reach 600 million by 2050. Asthma currently impacts approximately 262 million people worldwide. Consequently, the growing prevalence of respiratory diseases is fueling the interventional lung solutions market.

Major companies in the interventional lung solutions market are focusing on developing advanced technologies, such as the Ion Endoluminal System, to enhance the accuracy of lung cancer diagnostics, support minimally invasive procedures, and improve patient outcomes through precise navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, allowing accurate airway navigation to access small or hard-to-reach lung nodules. For example, in April 2024, H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit organization, launched a new Ion Robotic Bronchoscopy platform, advancing their interventional pulmonology program with sophisticated fiber-optic technology and a minimally invasive catheter system. This system utilizes fiber optics and the smallest catheter available to reach all regions of the lung. It features an ultra-thin, highly flexible catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of peripheral lung nodules that are difficult to access. The platform provides exceptional stability and accuracy for tissue sampling, allowing physicians to reach all 18 lung segments and supporting earlier detection of lung cancer.

In February 2025, Stryker Corporation, a US-based medical device company, acquired Inari Medical Inc. for an undisclosed amount. Through this acquisition, Stryker aims to expand its interventional endovascular portfolio by adding innovative, thrombolytic-free solutions for venous thromboembolism (VTE), including treatments for pulmonary embolism and deep vein thrombosis. Inari Medical Inc. is a US-based company specializing in interventional solutions for pulmonary conditions, with a particular focus on pulmonary embolism (PE) treatment.

Major companies operating in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., EndoMed Systems GmbH

North America was the largest region in the interventional lung solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional lung solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the interventional lung solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional lung solutions market consists of revenues earned by entities by providing services such as endobronchial valve placement, navigational bronchoscopy, lung volume reduction, and airway stenting. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional lung solutions market also consists of sales of products including bronchial thermoplasty devices, cryotherapy devices, bronchial stents, and biopsy forceps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Lung Solutions Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses interventional lung solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional lung solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional lung solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Needles; Pleuroscopes; Airway Stents; Other Product Types
  • 2) By Technology: Robotic Surgery; Laser Therapy; Electromagnetic Navigation Bronchoscopy
  • 3) By Procedure: Bronchoscopy; Thoracoscopy; Pleuroscopy; Other Procedures
  • 4) By Application: Lung Cancer Treatment; Chronic Obstructive Pulmonary Disease
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) BY Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Disposable Bronchoscopes
  • 2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles; Biopsy Needles
  • 3) By Pleuroscopes: Flexible Pleuroscopes; Semi-Rigid Pleuroscopes
  • 4) By Airway Stents: Metallic Stents; Silicone Stents; Hybrid Stents
  • 5) By Other Product Types: Bronchial Thermoplasty Devices; Lung Volume Reduction Devices; Electromagnetic Navigation Systems; Cryotherapy And Ablation Devices
  • Companies Mentioned: Johnson and Johnson; Siemens AG; Medtronic plc; FUJIFILM Holdings Corporation; GE Healthcare Technologies Inc.; Boston Scientific Corporation; Olympus Corporation; Intuitive Surgical Inc.; Smiths Medical Inc.; Cook Medical Inc.; Merit Medical Systems Inc.; Penumbra Inc.; Vygon SA; AngioDynamics Inc.; Vapotherm Inc.; Pulmonx Corporation; Broncus Medical Inc.; Thirona B.V.; Body Vision Medical Ltd.; EndoMed Systems GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Interventional Lung Solutions Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Interventional Lung Solutions Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Interventional Lung Solutions Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Interventional Lung Solutions Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Minimally Invasive Pulmonary Procedures
    • 4.2.2 Increasing Use Of Robotic Bronchoscopy Systems
    • 4.2.3 Growing Demand For Lung Volume Reduction Devices
    • 4.2.4 Expansion Of Image-Guided Interventional Lung Therapies
    • 4.2.5 Increasing Preference For Disposable Bronchoscopes

5. Interventional Lung Solutions Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Pulmonology Specialty Clinics
  • 5.4 Interventional Pulmonology Centers
  • 5.5 Diagnostic Imaging Centers

6. Interventional Lung Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Interventional Lung Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Interventional Lung Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Interventional Lung Solutions Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Interventional Lung Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Interventional Lung Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Interventional Lung Solutions Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Interventional Lung Solutions Market Segmentation

  • 9.1. Global Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bronchoscopes, Endobronchial Ultrasound Needles, Pleuroscopes, Airway Stents, Other Product Types
  • 9.2. Global Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Robotic Surgery, Laser Therapy, Electromagnetic Navigation Bronchoscopy
  • 9.3. Global Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bronchoscopy, Thoracoscopy, Pleuroscopy, Other Procedures
  • 9.4. Global Interventional Lung Solutions Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lung Cancer Treatment, Chronic Obstructive Pulmonary Disease
  • 9.5. Global Interventional Lung Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
  • 9.6. Global Interventional Lung Solutions Market, Sub-Segmentation Of Bronchoscopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Flexible Bronchoscopes, Rigid Bronchoscopes, Disposable Bronchoscopes
  • 9.7. Global Interventional Lung Solutions Market, Sub-Segmentation Of Endobronchial Ultrasound Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transbronchial Aspiration Needles, Biopsy Needles
  • 9.8. Global Interventional Lung Solutions Market, Sub-Segmentation Of Pleuroscopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Flexible Pleuroscopes, Semi-Rigid Pleuroscopes
  • 9.9. Global Interventional Lung Solutions Market, Sub-Segmentation Of Airway Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metallic Stents, Silicone Stents, Hybrid Stents
  • 9.10. Global Interventional Lung Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bronchial Thermoplasty Devices, Lung Volume Reduction Devices, Electromagnetic Navigation Systems, Cryotherapy And Ablation Devices

10. Interventional Lung Solutions Market Regional And Country Analysis

  • 10.1. Global Interventional Lung Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Interventional Lung Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Interventional Lung Solutions Market

  • 11.1. Asia-Pacific Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Interventional Lung Solutions Market

  • 12.1. China Interventional Lung Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Interventional Lung Solutions Market

  • 13.1. India Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Interventional Lung Solutions Market

  • 14.1. Japan Interventional Lung Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Interventional Lung Solutions Market

  • 15.1. Australia Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Interventional Lung Solutions Market

  • 16.1. Indonesia Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Interventional Lung Solutions Market

  • 17.1. South Korea Interventional Lung Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Interventional Lung Solutions Market

  • 18.1. Taiwan Interventional Lung Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Interventional Lung Solutions Market

  • 19.1. South East Asia Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Interventional Lung Solutions Market

  • 20.1. Western Europe Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Interventional Lung Solutions Market

  • 21.1. UK Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Interventional Lung Solutions Market

  • 22.1. Germany Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Interventional Lung Solutions Market

  • 23.1. France Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Interventional Lung Solutions Market

  • 24.1. Italy Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Interventional Lung Solutions Market

  • 25.1. Spain Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Interventional Lung Solutions Market

  • 26.1. Eastern Europe Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Interventional Lung Solutions Market

  • 27.1. Russia Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Interventional Lung Solutions Market

  • 28.1. North America Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Interventional Lung Solutions Market

  • 29.1. USA Interventional Lung Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Interventional Lung Solutions Market

  • 30.1. Canada Interventional Lung Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Interventional Lung Solutions Market

  • 31.1. South America Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Interventional Lung Solutions Market

  • 32.1. Brazil Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Interventional Lung Solutions Market

  • 33.1. Middle East Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Interventional Lung Solutions Market

  • 34.1. Africa Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Interventional Lung Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Interventional Lung Solutions Market Regulatory and Investment Landscape

36. Interventional Lung Solutions Market Competitive Landscape And Company Profiles

  • 36.1. Interventional Lung Solutions Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Interventional Lung Solutions Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Interventional Lung Solutions Market Company Profiles
    • 36.3.1. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Interventional Lung Solutions Market Other Major And Innovative Companies

  • Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., EndoMed Systems GmbH

38. Global Interventional Lung Solutions Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Interventional Lung Solutions Market

40. Interventional Lung Solutions Market High Potential Countries, Segments and Strategies

  • 40.1 Interventional Lung Solutions Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Interventional Lung Solutions Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Interventional Lung Solutions Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제